Literature DB >> 17360704

RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.

Philippe P Roux1, David Shahbazian, Hieu Vu, Marina K Holz, Michael S Cohen, Jack Taunton, Nahum Sonenberg, John Blenis.   

Abstract

Converging signals from the mammalian target of rapamycin (mTOR) and phosphoinositide 3-kinase (PI3K) pathways are well established to modulate translation initiation. Less is known regarding the molecular basis of protein synthesis regulated by other inputs, such as agonists of the Ras/extracellular signal-regulated kinase (ERK) signaling cascade. Ribosomal protein (rp) S6 is a component of the 40S ribosomal subunit that becomes phosphorylated at several serine residues upon mitogen stimulation, but the exact molecular mechanisms regulating its phosphorylation and the function of phosphorylated rpS6 is poorly understood. Here, we provide evidence that activation of the p90 ribosomal S6 kinases (RSKs) by serum, growth factors, tumor promoting phorbol esters, and oncogenic Ras is required for rpS6 phosphorylation downstream of the Ras/ERK signaling cascade. We demonstrate that while ribosomal S6 kinase 1 (S6K1) phosphorylates rpS6 at all sites, RSK exclusively phosphorylates rpS6 at Ser(235/236) in vitro and in vivo using an mTOR-independent mechanism. Mutation of rpS6 at Ser(235/236) reveals that phosphorylation of these sites promotes its recruitment to the 7-methylguanosine cap complex, suggesting that Ras/ERK signaling regulates assembly of the translation preinitiation complex. These data demonstrate that RSK provides an mTOR-independent pathway linking the Ras/ERK signaling cascade to the translational machinery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360704      PMCID: PMC3618456          DOI: 10.1074/jbc.M700906200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Regulation of cap-dependent translation by eIF4E inhibitory proteins.

Authors:  Joel D Richter; Nahum Sonenberg
Journal:  Nature       Date:  2005-02-03       Impact factor: 49.962

2.  RSK and MSK in MAP kinase signalling.

Authors:  Camilla Hauge; Morten Frödin
Journal:  J Cell Sci       Date:  2006-08-01       Impact factor: 5.285

Review 3.  When translation meets transformation: the mTOR story.

Authors:  J Averous; C G Proud
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

4.  The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.

Authors:  Rana Anjum; Philippe P Roux; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Curr Biol       Date:  2005-10-11       Impact factor: 10.834

5.  Characterization of S6K2, a novel kinase homologous to S6K1.

Authors:  K K Lee-Fruman; C J Kuo; J Lippincott; N Terada; J Blenis
Journal:  Oncogene       Date:  1999-09-09       Impact factor: 9.867

6.  mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events.

Authors:  Marina K Holz; Bryan A Ballif; Steven P Gygi; John Blenis
Journal:  Cell       Date:  2005-11-18       Impact factor: 41.582

7.  The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.

Authors:  David Shahbazian; Philippe P Roux; Virginie Mieulet; Michael S Cohen; Brian Raught; Jack Taunton; John W B Hershey; John Blenis; Mario Pende; Nahum Sonenberg
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

8.  Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis.

Authors:  Igor Ruvinsky; Nitzan Sharon; Tal Lerer; Hannah Cohen; Miri Stolovich-Rain; Tomer Nir; Yuval Dor; Philip Zisman; Oded Meyuhas
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 11.361

Review 9.  Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

Authors:  Igor Ruvinsky; Oded Meyuhas
Journal:  Trends Biochem Sci       Date:  2006-05-06       Impact factor: 13.807

10.  Structural bioinformatics-based design of selective, irreversible kinase inhibitors.

Authors:  Michael S Cohen; Chao Zhang; Kevan M Shokat; Jack Taunton
Journal:  Science       Date:  2005-05-27       Impact factor: 47.728

View more
  340 in total

1.  mTOR Signaling and Entrainment of the Mammalian Circadian Clock.

Authors:  Ruifeng Cao; Karl Obrietan
Journal:  Mol Cell Pharmacol       Date:  2010

2.  Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis.

Authors:  Jack T Lin; Emily A Stein; Michael T Wong; Krishna J Kalpathy; Leon L Su; Paul J Utz; William H Robinson; C Garrison Fathman
Journal:  Clin Immunol       Date:  2011-10-01       Impact factor: 3.969

3.  Time course of ribosomal kinase activity during hindlimb unloading.

Authors:  E A Lysenko; O V Turtikova; E V Kachaeva; I B Ushakov; B S Shenkman
Journal:  Dokl Biochem Biophys       Date:  2010-10-20       Impact factor: 0.788

4.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  EMBO J       Date:  2017-09-01       Impact factor: 11.598

5.  Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.

Authors:  Kirsty Sawicka; Alexander Pyronneau; Miranda Chao; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

6.  Revealing Dynamic Protein Acetylation across Subcellular Compartments.

Authors:  Josue Baeza; Alexis J Lawton; Jing Fan; Michael J Smallegan; Ian Lienert; Tejas Gandhi; Oliver M Bernhardt; Lukas Reiter; John M Denu
Journal:  J Proteome Res       Date:  2020-04-27       Impact factor: 4.466

7.  The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.

Authors:  Columba de la Parra; Elisa Otero-Franqui; Michelle Martinez-Montemayor; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

8.  Parallel measurement of dynamic changes in translation rates in single cells.

Authors:  Kyuho Han; Ariel Jaimovich; Gautam Dey; Davide Ruggero; Oded Meyuhas; Nahum Sonenberg; Tobias Meyer
Journal:  Nat Methods       Date:  2013-11-10       Impact factor: 28.547

9.  Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.

Authors:  Chaoyang Sun; Yong Fang; Jun Yin; Jian Chen; Zhenlin Ju; Dong Zhang; Xiaohua Chen; Christopher P Vellano; Kang Jin Jeong; Patrick Kwok-Shing Ng; Agda Karina B Eterovic; Neil H Bhola; Yiling Lu; Shannon N Westin; Jennifer R Grandis; Shiaw-Yih Lin; Kenneth L Scott; Guang Peng; Joan Brugge; Gordon B Mills
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

Review 10.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.